Earnings Per Share (Details) - shares |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 17, 2026 |
Jun. 08, 2026 |
Jun. 30, 2026 |
Jun. 30, 2026 |
|
| Public offering [Member] | ||||
| Earnings Per Share [Line Items] | ||||
| Sale of common stock | 33,333,334 | |||
| Purchase of common stock | 1,533,333 | 1,533,333 | ||
| Over-allotment option [Member] | ||||
| Earnings Per Share [Line Items] | ||||
| Issuance of additional shares of common stock | 4,999,999 |
| X | ||||||||||
- Definition Issuance of additional shares of common stock. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|